For UK registered practitioners

Register to view pricing and order

Pricing and ordering are restricted to UK registered practitioners. Approval typically takes one to two working days.

Register as a practitioner Already registered? Sign in

GPhC pharmacy registration no. 9012378

Nucleofill 20 (medium) 2% 1.5ml Syringe SHORT DATED 03/2026

Nucleofill 20 (medium) 2% 1.5ml Syringe SHORT DATED 03/2026

Stock Item
Skip to product information
Nucleofill 20 (medium) 2% 1.5ml Syringe SHORT DATED 03/2026
1/3

Nucleofill 20 (medium) 2% 1.5ml Syringe SHORT DATED 03/2026

Supply

Prescription items are supplied only against a valid, patient-specific prescription.

Description

Nucleofill 20 (Medium) is a new line of sterile sodium DNA-based gel with hydrating properties, specific for young skin. As an anti-ageing treatment, Nucleofill is designed to improve skin elasticity and tightness as well as aid in the prevention of wrinkles.

supports skin regeneration as well as the outwardly visible improvement of the skin’s appearance.

  • Reduces light to moderate wrinkles such as perioral wrinkles or creases on the cheeks.
  • Reduces medium-sized scars and stretch marks.
  • Effectively tightens sagging or drooping skin in areas such as the face, neck, hands, or abdomen.
  • Even the thighs and buttocks can be treated!

For particularly dry or oxidatively damaged skin, Nucleofill 20 is perfectly suited, as it provides the skin of any condition with deep-acting moisture as well as extensive protection against free radicals. It also has an antioxidant effect based on polymerised polynucleotides. Nucleofill 20 also stimulates cell formation by injecting it into the dermis for one to several sessions.

Ingredients: Aqua, Sodium DNA, Sodium Chloride

Compatible with a mesotherapy protocol, not intended for volume enhancement

No needles included.

Prescription supply

Prescription-only medicines (POM) are always dispensed against a valid, patient-specific prescription and are never available as clinic stock, under any circumstances.

Where a product genuinely supports both routes, you choose whether you are ordering that item on prescription for a named patient or as clinic stock under your professional responsibility when you select it on the product page.

Named-patient prescription supply. Items chosen for a named patient are dispensed against your prescription. The order is held for Superintendent Pharmacist review before despatch. Prescription supply is zero-rated for VAT.

Clinic stock supply. Where eligible, items chosen as clinic stock are supplied under your professional responsibility for use in your practice. Standard VAT applies at checkout. This route is never offered for prescription-only medicines.

Orders containing prescription-only medicines are held until the Superintendent Pharmacist has cleared the prescription. Same-day dispatch applies once cleared.

For questions about prescription supply, contact admin@longevapharma.com or reply to your order confirmation email.

Delivery & Returns

Delivery: Dispatch and delivery depend on stock, cleared payment, customer eligibility and any required prescription or pharmacy checks. Delivery estimates are not guarantees. See our Shipping and Delivery Policy.

Returns: Because storage history, product integrity, traceability and chain of custody cannot be verified after regulated healthcare goods leave our control, medicines, cold-chain goods, sterile products, injectables and other regulated products cannot normally be returned after dispatch. This does not affect remedies for goods supplied incorrectly, damaged or defective. See our Returns and Refunds Policy.

Cold chain: Temperature-sensitive products must be received promptly and transferred to the required storage conditions. If damage or a suspected temperature excursion is identified, quarantine the goods, retain all packaging and contact Longeva Pharma before use.

You may also like